NO20033622L - Fremgangsmate for behandling av demyeliniserende sykdommer eller tilstander - Google Patents

Fremgangsmate for behandling av demyeliniserende sykdommer eller tilstander

Info

Publication number: NO20033622L
Authority: NO; Norway
Prior art keywords: treatment; conditions; demyelinating diseases; demyelinating; diseases
Prior art date: 2001-02-15

Application number

NO20033622A

Other languages

English (en)

Other versions

NO20033622D0 (no

Inventor

Craig Paul Smith

Michel P Rathbone

Margaret Petty

David Rampe

Original Assignee

Aventis Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-15

Filing date

2003-08-14

Publication date

2003-10-06

2003-08-14 Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc

2003-08-14 Publication of NO20033622D0 publication Critical patent/NO20033622D0/no

2003-10-06 Publication of NO20033622L publication Critical patent/NO20033622L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20033622A 2001-02-15 2003-08-14 Fremgangsmate for behandling av demyeliniserende sykdommer eller tilstander NO20033622L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US26884601P	2001-02-15	2001-02-15
GBGB0119435.6A GB0119435D0 (en)	2001-02-15	2001-08-09	Method of treating of demyelinating diseases or conditions
PCT/US2002/005501 WO2002064126A2 (en)	2001-02-15	2002-02-14	Method of treating of demyelinating diseases or conditions

Publications (2)

Publication Number	Publication Date
NO20033622D0 NO20033622D0 (no)	2003-08-14
NO20033622L true NO20033622L (no)	2003-10-06

Family

ID=23024747

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033622A NO20033622L (no)	2001-02-15	2003-08-14	Fremgangsmate for behandling av demyeliniserende sykdommer eller tilstander

Country Status (39)

Country	Link
US (10)	US6967210B2 (no)
EP (1)	EP1368031A2 (no)
JP (3)	JP2004518711A (no)
KR (3)	KR100951540B1 (no)
CN (2)	CN1529598A (no)
AP (1)	AP1749A (no)
AR (1)	AR035750A1 (no)
AU (3)	AU2002247200B9 (no)
BR (1)	BR0207272A (no)
CA (1)	CA2438712A1 (no)
CO (1)	CO5390085A1 (no)
CR (1)	CR7023A (no)
CZ (1)	CZ20032172A3 (no)
EA (2)	EA011319B1 (no)
EC (1)	ECSP024218A (no)
EE (1)	EE200300363A (no)
GB (1)	GB0119435D0 (no)
HK (1)	HK1080361B (no)
HR (1)	HRP20030652A2 (no)
HU (1)	HUP0303203A3 (no)
IL (2)	IL157341A0 (no)
MA (1)	MA26152A1 (no)
ME (1)	MEP21208A (no)
MX (1)	MXPA03006110A (no)
MY (1)	MY157745A (no)
NO (1)	NO20033622L (no)
NZ (4)	NZ539159A (no)
OA (1)	OA12549A (no)
PA (1)	PA8540101A1 (no)
PE (1)	PE20040175A1 (no)
PL (1)	PL363638A1 (no)
SG (1)	SG134170A1 (no)
SK (1)	SK10392003A3 (no)
TR (4)	TR200301330T2 (no)
TW (1)	TWI325319B (no)
UA (2)	UA80394C2 (no)
WO (1)	WO2002064126A2 (no)
YU (1)	YU62903A (no)
ZA (1)	ZA200306124B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0119435D0 (en) *	2001-02-15	2001-10-03	Aventis Pharm Prod Inc	Method of treating of demyelinating diseases or conditions
JP2006511624A (ja) *	2002-12-20	2006-04-06	ダイノジェンファーマシューティカルズ，インコーポレイテッド	α２δサブユニット・カルシウム・チャンネル調節因子を使用する無痛性膀胱障害を処置するための方法
CA2514581A1 (en) *	2003-01-30	2004-08-12	Dynogen Pharmaceuticals, Inc.	Methods of treating lower urinary tract disorders using sodium channel modulators
AU2004224322A1 (en) *	2003-03-21	2004-10-07	Dynogen Pharmaceuticals, Inc.	Methods of treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators
GT200500063A (es) *	2004-04-01	2005-10-14		Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
GB0510164D0 (en) *	2005-04-28	2005-06-22	Paradigm Therapeutics Ltd	Ion channel
FR2892021B1 (fr) *	2005-10-19	2008-01-04	Urogene	Traitement de l'incontinence urinaire d'effort et mixte
FR2892022B1 (fr) *	2005-10-19	2008-01-04	Urogene Sa	Traitement des symptomes de l'irritation de la vessie
US8420593B1 (en) *	2006-06-16	2013-04-16	Landon C. G. Miller	Compositions and methods for regulating membrane potential
DE102008044844B4 (de) *	2008-08-28	2018-08-30	Siemens Healthcare Gmbh	Verfahren zur Ermittlung einer Schwächungskarte zur Verwendung in der Positronenemissionstomographie und von Homogenitätsinformationen des Magnetresonanzmagnetfeldes
WO2011118364A1 (en) *	2010-03-26	2011-09-29	Semiconductor Energy Laboratory Co., Ltd.	Semiconductor device
WO2012009204A1 (en) *	2010-07-15	2012-01-19	The Trustees Of Columbia University In The City Of New York	Methods for diagnosing and treating concussive disorders
JP2014503596A (ja) *	2011-01-28	2014-02-13	アコーダセラピューティクス，インコーポレーテッド	脳性麻痺を治療するためのカリウムチャネル遮断薬の使用
TWI592156B (zh) *	2011-10-04	2017-07-21	艾可達醫療公司	使用胺基吡啶以治療與中風有關之感覺動作損傷之方法
WO2017151409A1 (en)	2016-02-29	2017-09-08	University Of Florida Research Foundation, Incorporated	Chemotherapeutic methods
US11730769B2 (en)	2017-12-22	2023-08-22	Children's Medical Center Corporation	Compositions and methods for Williams Syndrome (WS) therapy
WO2022159086A1 (en) *	2021-01-20	2022-07-28	Rush University Medical Center	Improved treatment for globoid cell leukodsytrophy or krabbe disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE115143T1 (de) *	1987-04-24	1994-12-15	Hoechst Roussel Pharma	N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel.
US4880822A (en) *	1987-04-24	1989-11-14	Hoechst-Roussel Pharmaceuticals, Inc.	N-(pyridinyl)-1H-indol-1-amines
US4970218A (en) *	1987-04-24	1990-11-13	Hoechst-Roussel Pharmaceuticals Inc.	N-(pyridinyl)-1H-indol-1-amines
DE69016531T2 (de) *	1989-08-02	1995-07-06	Hoechst Roussel Pharma	2,3-Dihydro-1-(pyridinylamino)-indole, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
US5214038A (en) *	1991-04-15	1993-05-25	Hoechst-Roussel Pharmaceuticals Inc.	1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
DE4325491A1 (de) *	1993-07-29	1995-02-02	Boehringer Ingelheim Kg	Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels
US5459274A (en) *	1994-05-13	1995-10-17	Hoechst-Roussel Pharmaceuticals Inc.	Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
US5565475A (en) *	1994-11-08	1996-10-15	Muhlhauser; Mark A.	Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
EP0731108A1 (en) *	1995-03-10	1996-09-11	Boehringer Mannheim Gmbh	Method of manufacturing a therapeutic agent for the regeneration of oligodendrocytes
FR2754147B1 (fr)	1996-10-03	2000-02-04	Mbh Technologies Sa	Installation et procede pour le traitement de carcasses
EP1056754B1 (en) *	1998-01-29	2003-10-22	Bristol-Myers Squibb Company	Phosphate derivatives of diaryl 1,3,4-oxadiazolone
WO2001004091A1 (en) *	1999-07-09	2001-01-18	Ortho-Mcneil Pharmaceutical, Inc.	Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
GB0119435D0 (en) *	2001-02-15	2001-10-03	Aventis Pharm Prod Inc	Method of treating of demyelinating diseases or conditions

2001
- 2001-08-09 GB GBGB0119435.6A patent/GB0119435D0/en not_active Ceased
2002
- 2002-02-14 KR KR1020037010691A patent/KR100951540B1/ko not_active Expired - Fee Related
- 2002-02-14 AU AU2002247200A patent/AU2002247200B9/en not_active Ceased
- 2002-02-14 NZ NZ539159A patent/NZ539159A/en unknown
- 2002-02-14 HR HR20030652A patent/HRP20030652A2/hr not_active Application Discontinuation
- 2002-02-14 SK SK1039-2003A patent/SK10392003A3/sk unknown
- 2002-02-14 AP APAP/P/2003/002834A patent/AP1749A/en active
- 2002-02-14 UA UA2003098376A patent/UA80394C2/uk unknown
- 2002-02-14 CZ CZ20032172A patent/CZ20032172A3/cs unknown
- 2002-02-14 CA CA002438712A patent/CA2438712A1/en not_active Abandoned
- 2002-02-14 EE EEP200300363A patent/EE200300363A/xx unknown
- 2002-02-14 TR TR2003/01330T patent/TR200301330T2/xx unknown
- 2002-02-14 IL IL15734102A patent/IL157341A0/xx unknown
- 2002-02-14 NZ NZ544720A patent/NZ544720A/en unknown
- 2002-02-14 CN CNA028048644A patent/CN1529598A/zh active Pending
- 2002-02-14 US US10/076,191 patent/US6967210B2/en not_active Expired - Lifetime
- 2002-02-14 PL PL02363638A patent/PL363638A1/xx not_active Application Discontinuation
- 2002-02-14 EA EA200300882A patent/EA011319B1/ru not_active IP Right Cessation
- 2002-02-14 HU HU0303203A patent/HUP0303203A3/hu unknown
- 2002-02-14 TR TR2008/00692T patent/TR200800692T2/xx unknown
- 2002-02-14 EP EP02714974A patent/EP1368031A2/en not_active Withdrawn
- 2002-02-14 ME MEP-212/08A patent/MEP21208A/xx unknown
- 2002-02-14 BR BR0207272-6A patent/BR0207272A/pt not_active IP Right Cessation
- 2002-02-14 TR TR2008/00693T patent/TR200800693T2/xx unknown
- 2002-02-14 SG SG200505802-9A patent/SG134170A1/en unknown
- 2002-02-14 OA OA1200300199A patent/OA12549A/en unknown
- 2002-02-14 MX MXPA03006110A patent/MXPA03006110A/es active IP Right Grant
- 2002-02-14 TR TR2008/00691T patent/TR200800691T2/xx unknown
- 2002-02-14 YU YU62903A patent/YU62903A/sh unknown
- 2002-02-14 KR KR1020087031854A patent/KR20090005254A/ko not_active Ceased
- 2002-02-14 NZ NZ527011A patent/NZ527011A/en unknown
- 2002-02-14 EA EA200600896A patent/EA012409B1/ru not_active IP Right Cessation
- 2002-02-14 WO PCT/US2002/005501 patent/WO2002064126A2/en not_active Ceased
- 2002-02-14 CN CNB2005100597348A patent/CN100522164C/zh not_active Expired - Fee Related
- 2002-02-14 KR KR1020087031855A patent/KR100951542B1/ko not_active Expired - Fee Related
- 2002-02-14 NZ NZ556697A patent/NZ556697A/en unknown
- 2002-02-14 JP JP2002563920A patent/JP2004518711A/ja not_active Ceased
- 2002-02-15 EC EC2002004218A patent/ECSP024218A/es unknown
- 2002-02-15 AR ARP020100540A patent/AR035750A1/es unknown
- 2002-02-15 MY MYPI20020518A patent/MY157745A/en unknown
- 2002-02-15 CO CO02013025A patent/CO5390085A1/es not_active Application Discontinuation
- 2002-02-15 TW TW091102861A patent/TWI325319B/zh not_active IP Right Cessation
- 2002-02-18 PA PA20028540101A patent/PA8540101A1/es unknown
- 2002-02-26 PE PE2002000159A patent/PE20040175A1/es not_active Application Discontinuation
2003
- 2003-07-11 MA MA27235A patent/MA26152A1/fr unknown
- 2003-07-16 CR CR7023A patent/CR7023A/es unknown
- 2003-08-07 ZA ZA200306124A patent/ZA200306124B/xx unknown
- 2003-08-11 IL IL157341A patent/IL157341A/en not_active IP Right Cessation
- 2003-08-14 NO NO20033622A patent/NO20033622L/no not_active Application Discontinuation
2004
- 2004-02-03 US US10/770,655 patent/US20040157888A1/en not_active Abandoned
- 2004-02-03 US US10/770,656 patent/US20040157889A1/en not_active Abandoned
2005
- 2005-03-14 US US11/079,327 patent/US7230015B2/en not_active Expired - Lifetime
- 2005-03-14 US US11/079,366 patent/US7179821B2/en not_active Expired - Lifetime
- 2005-09-27 US US11/236,145 patent/US7534803B2/en not_active Expired - Fee Related
2006
- 2006-01-05 HK HK06100186.8A patent/HK1080361B/zh not_active IP Right Cessation
- 2006-04-04 UA UAA200603708A patent/UA88773C2/ru unknown
2008
- 2008-03-13 AU AU2008201179A patent/AU2008201179B2/en not_active Ceased
2009
- 2009-04-06 JP JP2009091807A patent/JP2009185045A/ja not_active Abandoned
- 2009-04-29 US US12/420,381 patent/US20090270458A1/en not_active Abandoned
- 2009-04-29 US US12/420,390 patent/US20090281147A1/en not_active Abandoned
- 2009-04-29 US US12/420,407 patent/US20090209594A1/en not_active Abandoned
- 2009-04-29 US US12/420,416 patent/US20090209595A1/en not_active Abandoned
- 2009-11-19 AU AU2009238332A patent/AU2009238332A1/en not_active Abandoned
2010
- 2010-02-16 JP JP2010030929A patent/JP2010120958A/ja not_active Abandoned

Also Published As

Publication number	Publication date
US20050234105A1 (en)	2005-10-20
MA26152A1 (fr)	2004-07-01
HUP0303203A2 (hu)	2003-12-29
MY157745A (en)	2016-07-15
TR200800692T2 (tr)	2008-03-21
AU2002247200B2 (en)	2007-12-13
US20030105150A1 (en)	2003-06-05
US20090209594A1 (en)	2009-08-20
TR200800691T2 (tr)	2008-03-21
US20090281147A1 (en)	2009-11-12
CN1529598A (zh)	2004-09-15
AU2002247200B9 (en)	2008-07-10
JP2004518711A (ja)	2004-06-24
US20090209595A1 (en)	2009-08-20
US7230015B2 (en)	2007-06-12
WO2002064126A2 (en)	2002-08-22
YU62903A (sh)	2006-05-25
EA200600896A1 (ru)	2006-08-25
EA011319B1 (ru)	2009-02-27
KR20040014459A (ko)	2004-02-14
KR20090005254A (ko)	2009-01-12
EP1368031A2 (en)	2003-12-10
IL157341A0 (en)	2004-02-19
NZ556697A (en)	2009-01-31
CR7023A (es)	2003-11-17
HUP0303203A3 (en)	2007-11-28
TR200301330T2 (tr)	2004-12-21
US7179821B2 (en)	2007-02-20
CZ20032172A3 (cs)	2004-01-14
CO5390085A1 (es)	2004-04-30
IL157341A (en)	2010-11-30
WO2002064126A3 (en)	2003-02-20
NZ544720A (en)	2007-08-31
KR20090005255A (ko)	2009-01-12
KR100951542B1 (ko)	2010-04-09
UA80394C2 (en)	2007-09-25
ZA200306124B (en)	2004-11-08
OA12549A (en)	2006-06-05
EE200300363A (et)	2003-10-15
US6967210B2 (en)	2005-11-22
CA2438712A1 (en)	2002-08-22
TR200800693T2 (tr)	2008-07-21
MEP21208A (en)	2010-06-10
HK1080361B (zh)	2009-10-30
AR035750A1 (es)	2004-07-07
US7534803B2 (en)	2009-05-19
SG134170A1 (en)	2007-08-29
US20050159456A1 (en)	2005-07-21
CN100522164C (zh)	2009-08-05
US20040157888A1 (en)	2004-08-12
UA88773C2 (ru)	2009-11-25
HRP20030652A2 (en)	2005-06-30
US20040157889A1 (en)	2004-08-12
US20060025452A1 (en)	2006-02-02
PL363638A1 (en)	2004-11-29
AU2009238332A1 (en)	2009-12-10
US20090270458A1 (en)	2009-10-29
PA8540101A1 (es)	2003-09-05
EA012409B1 (ru)	2009-10-30
CN1679564A (zh)	2005-10-12
HK1080361A1 (zh)	2006-04-28
AU2008201179A1 (en)	2008-04-03
NZ539159A (en)	2006-11-30
NO20033622D0 (no)	2003-08-14
ECSP024218A (es)	2003-09-24
EA200300882A1 (ru)	2003-12-25
KR100951540B1 (ko)	2010-04-09
PE20040175A1 (es)	2004-03-29
MXPA03006110A (es)	2005-07-01
JP2009185045A (ja)	2009-08-20
GB0119435D0 (en)	2001-10-03
AU2008201179B2 (en)	2009-08-20
JP2010120958A (ja)	2010-06-03
AP2003002834A0 (en)	2003-09-30
SK10392003A3 (sk)	2004-01-08
TWI325319B (en)	2010-06-01
AP1749A (en)	2007-06-13
BR0207272A (pt)	2004-02-10
NZ527011A (en)	2005-07-29

Publication	Publication Date	Title
NO20033594L (no)	2003-10-02	Fenetanolamin-derivater for behandling av luftveissykdommer
DE60202169D1 (de)	2005-01-13	Verfahren zur Herstellung von Flockungsmittel zur Wasserbehandlung
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60230425D1 (de)	2009-01-29	Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
NO20042680L (no)	2004-06-25	Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20033622L (no)	2003-10-06	Fremgangsmate for behandling av demyeliniserende sykdommer eller tilstander
DE50201891D1 (de)	2005-02-03	Verfahren zur herstellung von 1-octen
DE60204466D1 (de)	2005-07-07	Integrinhemmer zur behandlung von augenkrankheiten
DE60223070D1 (de)	2007-11-29	Verfahren zur herstellung von dihalogenadamantanen
NO20040278L (no)	2004-01-21	Fremgangsmate for fremstilling av perindopril
DE60208562D1 (de)	2006-03-30	Verfahren zur herstellung von tagatose
DE60219193D1 (de)	2007-05-10	Verfahren zur herstellung von silylorganomercaptanen
DE60208738D1 (de)	2006-04-06	Verfahren zur Herstellung von Chlorfluorpolyoxyalkylenolen
DE60236743D1 (de)	2010-07-29	Zur behandlung androgenabhängiger krankheiten
FI20012170A0 (fi)	2001-11-09	Menetelmä lauhteiden käsittelemiseksi
NO20044814L (no)	2004-01-07	Fremgangsmate for fremstilling av combretastaniner
NO20035538D0 (no)	2003-12-11	Fremgangsmåte for fremstilling av zaleplon
DE60233589D1 (de)	2009-10-15	Verfahren zur herstellung von echinocandinderivaten
NO20023445L (no)	2003-01-20	Fremgangsmåte for fremstilling av peptider
DE50210487D1 (de)	2007-08-30	Verfahren zur Herstellung von 1-Amino-4-hydroxyanthrachinonen
NO20020784L (no)	2002-02-18	Medikament for behandling av brudd
NO20035586D0 (no)	2003-12-15	Fremgangsmåte for fremstilling av cykloheksanol-derivater
DE60209171D1 (de)	2006-04-20	Verfahren zur Herstellung von Bromfluorenen
NO20012612L (no)	2001-07-17	Isonipecotamider for behandlingen av integrin-formidlede sykdommer
AU2002246151A1 (en)	2003-04-10	Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases

Legal Events

Date	Code	Title	Description
2011-08-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application